Results 101 to 110 of about 10,981 (164)

Determinants of primary healthcare physicians' knowledge of diabetic kidney disease. [PDF]

Afr J Prim Health Care Fam Med
Fadili W.
europepmc   +1 more source

Atherogenic index of plasma and risk of diabetic nephropathy in type 2 diabetes: A meta‑analysis. [PDF]

Biomol Biomed
Min D, Zhao J, Liu M.
europepmc   +1 more source

The mediating effect role of methylmalonic acid on the association between oxidative balance score and diabetic kidney disease: a cross-sectional study from NHANES 2011-2014. [PDF]

Ren Fail
Yang H, Ma L, Shen L, Yao W, Huang H, Shen Y.   +5 more
europepmc   +1 more source

Assessing the association of FIB-4 index with diabetic kidney disease in patients with diabetes mellitus: a cross-sectional and retrospective study utilizing NHANES and clinical data. [PDF]

Front Endocrinol (Lausanne)
Yang R, Liu Y, Li J.
europepmc   +1 more source

Heterogeneous Kidney Patterns in Diabetic Patients Following SGLT2 Inhibitor Use. [PDF]

J Korean Med Sci
Bae S, Yun D, Kim J, Park S, Kim YC, Kim DK, Oh KH, Joo KW, Kim YS, Han SS.   +9 more
europepmc   +1 more source

Analysis of Circulating and Urinary Levels of hsa-miRNA-770-5p in Diabetic Nephropathy. [PDF]

Biomolecules
Nikolov D, Nikolov G, Geneva-Popova M, Popova-Belova S, Naydenov M, Karusheva MG.   +5 more
europepmc   +1 more source

Global Dialysis Perspective: Romania. [PDF]

Kidney360
Stefan G, Mircescu G.
europepmc   +1 more source

Integration of digital physicalomics and dual-fluid metabolomics flux ratios reveals tubular secretory dysfunction in early diabetic kidney disease. [PDF]

Front Endocrinol (Lausanne)
Zhang H, Cai Q, Gao J, Wang F, Zhang L, Zhao H, Ren X, Zhang M.   +7 more
europepmc   +1 more source

NLRP3 Inflammasome Inhibition Attenuates Diabetic Kidney Injury via the Suppression of Ferroptosis: Mechanistic Insights from In Vivo and In Vitro Models. [PDF]

Int J Mol Sci
Tian Z, Yin Q, Zhou C, Wu X, Liu F, Li J.   +5 more
europepmc   +1 more source